Advertisement
Advertisement

TNGX

TNGX logo

Tango Therapeutics, Inc.

29.61
USD
Sponsored
-1.65
-5.28%
Jul 01, 13:04 UTC -4
Open

TNGX Earnings Reports

Positive Surprise Ratio

TNGX beat 12 of 19 last estimates.

63%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.32
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 25 (Revenue/ EPS)
-100.00%
/
-8.57%

Tango Therapeutics, Inc. earnings per share and revenue

On May 13, 2026, TNGX reported earnings of -0.32 USD per share (EPS) for Q1 26, missing the estimate of -0.31 USD, resulting in a -0.13% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.51% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 8 analysts forecast an EPS of -0.32 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
FAQ
For Q1 2026, Tango Therapeutics, Inc. reported EPS of -$0.32, missing estimates by -0.13%, and revenue of $0.00, 0% as expectations.
The stock price moved down -2.51%, changed from $25.51 before the earnings release to $24.87 the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on 8 analysts, Tango Therapeutics, Inc. is expected to report EPS of -$0.32 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement